Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer

Corey Speers, Anna Tsimelzon, K. Sexton, Ashley M. Herrick, Carolina Gutiérrez, Aedín C. Culhane, John Quackenbush, Susan G. Hilsenbeck, Jenny C. Chang, Powel H. BrownClinical 2009 · DOI

Abstract

This study identifies a list of kinases that are prognostic and may serve as druggable targets for the treatment of ER-negative breast cancer.
BibTeX
@inproceedings{speers2009identification,
  author = {Corey Speers and Anna Tsimelzon and K. Sexton and Ashley M. Herrick and Carolina Gutiérrez and Aedín C. Culhane and John Quackenbush and Susan G. Hilsenbeck and Jenny C. Chang and Powel H. Brown},
  title = {{Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer}},
  booktitle = {Clinical},
  year = {2009},
  doi = {10.1158/1078-0432.ccr-09-1107},
}

Loading related content...

Figure